Amiodarone Intravenous and Sodium polystyrene sulfonate Rectal
Determining the interaction of Amiodarone Intravenous and Sodium polystyrene sulfonate Rectal and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Talk to your doctor before using amiodarone together with sodium polystyrene sulfonate. Combining these medications can increase the risk of an irregular heart rhythm that may be serious. If your doctor prescribes these medications together, you may need regular monitoring of your electrolyte (magnesium, potassium) levels as well as other tests to safely use both medications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with amiodarone. In addition, you should let your doctor know if you experience signs of electrolyte disturbance such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Amiodarone can cause dose-related prolongation of the QT interval. Theoretically, coadministration with agents that can produce hypokalemia and/or hypomagnesemia (e.g., potassium-wasting diuretics, amphotericin B, cation exchange resins, stimulant laxatives) may result in elevated risk of ventricular arrhythmias, including ventricular tachycardia and torsades de pointes, because of additive arrhythmogenic potential.
MANAGEMENT: Coadministration of amiodarone with medications that can cause potassium and/or magnesium disturbances should generally be avoided. Serum electrolytes should be evaluated and any abnormalities corrected prior to initiating therapy with amiodarone. Patients should be advised to seek medical attention if they experience symptoms that could indicate the occurrence of torsades de pointes such as dizziness, palpitations, or syncope.
- Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5
- "Product Information. Amiodarone Hydrochloride (amiodarone)." Bedford Laboratories, Bedford, OH.
Generic Name: amiodarone
Brand name: Pacerone, Cordarone, Nexterone
Synonyms: Amiodarone
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate (Rectal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amiodarone Intravenous-Sodium Polystyrene Sulfonate Suspension
- Amiodarone Intravenous-Sodium Sulf/Potassium Sulf/Mag Sulf/Polyethylene Glycol-Electrolyte Soln
- Amiodarone Intravenous-Sodium Sulfacetamide and Sulfur Aqueous Gel
- Amiodarone Intravenous-Sodium Sulfacetamide and Sulfur Cleanser
- Amiodarone Intravenous-Sodium Sulfacetamide and Sulfur Cream
- Amiodarone Intravenous-Sodium Sulfacetamide and Sulfur Foam
- Sodium polystyrene sulfonate Rectal-Amiodarone Intravenous, Oral
- Sodium polystyrene sulfonate Rectal-Amiodarone Tablets
- Sodium polystyrene sulfonate Rectal-Amitiza
- Sodium polystyrene sulfonate Rectal-Amitriptyline
- Sodium polystyrene sulfonate Rectal-Amitriptyline and chlordiazepoxide
- Sodium polystyrene sulfonate Rectal-Amitriptyline and perphenazine